{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T14:59:54Z","timestamp":1792076394972,"version":"4.4.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T00:00:00Z","timestamp":1764892800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T00:00:00Z","timestamp":1764892800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-27173-9","type":"journal-article","created":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T09:45:01Z","timestamp":1764927901000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Discovering bioactive pharmaceuticals from natural products for type 2 diabetes mellitus using network pharmacology, molecular docking, and molecular dynamics"],"prefix":"10.1038","volume":"15","author":[{"given":"Bita","family":"Rahmani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hossein","family":"Akbari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hadise","family":"Esmaeili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahabaddin","family":"Solaimanian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meysam","family":"Mobasheri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Reza","family":"Shiri-Shahsavar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,5]]},"reference":[{"key":"27173_CR1","doi-asserted-by":"publisher","first-page":"15019","DOI":"10.1038\/nrdp.2015.19","volume":"1","author":"RA DeFronzo","year":"2015","unstructured":"DeFronzo, R. A. et al. Type 2 diabetes mellitus. Nat. Rev. Dis. Primers. 1, 15019. https:\/\/doi.org\/10.1038\/nrdp.2015.19 (2015).","journal-title":"Nat. Rev. Dis. Primers"},{"key":"27173_CR2","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/S0140-6736(23)01301-6","volume":"402","author":"KL Ong","year":"2023","unstructured":"Ong, K. L. et al. Global, regional, and National burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the global burden of disease study 2021. Lancet 402, 203\u2013234. https:\/\/doi.org\/10.1016\/S0140-6736(23)01301-6 (2023).","journal-title":"Lancet"},{"key":"27173_CR3","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1111\/dom.12977","volume":"19","author":"DR Owens","year":"2017","unstructured":"Owens, D. R., Monnier, L. & Barnett, A. H. Future challenges and therapeutic opportunities in type 2 diabetes: changing the paradigm of current therapy. Diabetes Obes. Metab. 19, 1339\u20131352. https:\/\/doi.org\/10.1111\/dom.12977 (2017).","journal-title":"Diabetes Obes. Metab."},{"key":"27173_CR4","doi-asserted-by":"publisher","first-page":"155332","DOI":"10.1016\/j.metabol.2022.155332","volume":"137","author":"A DeMarsilis","year":"2022","unstructured":"DeMarsilis, A. et al. Pharmacotherapy of type 2 diabetes: an update and future directions. Metabolism 137, 155332. https:\/\/doi.org\/10.1016\/j.metabol.2022.155332 (2022).","journal-title":"Metabolism"},{"key":"27173_CR5","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1038\/s41366-023-01369-3","volume":"47","author":"MA Ansari","year":"2023","unstructured":"Ansari, M. A. et al. Emerging therapeutic options in the management of diabetes: recent trends, challenges and future directions. Int. J. Obes. 47, 1179\u20131199. https:\/\/doi.org\/10.1038\/s41366-023-01369-3 (2023).","journal-title":"Int. J. Obes."},{"key":"27173_CR6","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1111\/dom.12854","volume":"19","author":"F Bonnet","year":"2017","unstructured":"Bonnet, F. & Scheen, A. Understanding and overcoming Metformin Gastrointestinal intolerance. Diabetes Obes. Metab. 19, 473\u2013481. https:\/\/doi.org\/10.1111\/dom.12854 (2017).","journal-title":"Diabetes Obes. Metab."},{"key":"27173_CR7","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.metabol.2015.10.014","volume":"65","author":"R DeFronzo","year":"2016","unstructured":"DeFronzo, R., Fleming, G. A., Chen, K. & Bicsak, T. A. Metformin-associated lactic acidosis: current perspectives on causes and risk. Metabolism 65, 20\u201329. https:\/\/doi.org\/10.1016\/j.metabol.2015.10.014 (2016). https:\/\/doi.org\/https:\/\/doi.org\/","journal-title":"Metabolism"},{"key":"27173_CR8","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.2337\/dc17-0595","volume":"40","author":"A Douros","year":"2017","unstructured":"Douros, A. et al. Pharmacologic differences of sulfonylureas and the risk of adverse cardiovascular and hypoglycemic events. Diabetes Care. 40, 1506\u20131513. https:\/\/doi.org\/10.2337\/dc17-0595 (2017).","journal-title":"Diabetes Care"},{"key":"27173_CR9","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1007\/s13300-024-01612-8","volume":"15","author":"I Sahin","year":"2024","unstructured":"Sahin, I., Bakiner, O., Demir, T., Sari, R. & Atmaca, A. Current position of Gliclazide and sulfonylureas in the contemporary treatment paradigm for type 2 diabetes: A scoping review. Diabetes Therapy. 15, 1687\u20131716. https:\/\/doi.org\/10.1007\/s13300-024-01612-8 (2024).","journal-title":"Diabetes Therapy"},{"key":"27173_CR10","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.2217\/pgs.14.162","volume":"15","author":"D Della-Morte","year":"2014","unstructured":"Della-Morte, D. et al. Pharmacogenomics and pharmacogenetics of thiazolidinediones: role in diabetes and cardiovascular risk factors. Pharmacogenomics 15, 2063\u20132082. https:\/\/doi.org\/10.2217\/pgs.14.162 (2014).","journal-title":"Pharmacogenomics"},{"key":"27173_CR11","doi-asserted-by":"publisher","first-page":"406","DOI":"10.4158\/EP.9.5.406","volume":"9","author":"M Sunder","year":"2003","unstructured":"Sunder, M., Chang, A. R., Henry, R. R. & Thiazolidinediones Peripheral Edema, and type 2 diabetes: Incidence, Pathophysiology, and clinical implications. Endocr. Pract. 9, 406\u2013416. https:\/\/doi.org\/10.4158\/EP.9.5.406 (2003).","journal-title":"Endocr. Pract."},{"key":"27173_CR12","doi-asserted-by":"publisher","first-page":"520","DOI":"10.3399\/bjgp09X453440","volume":"59","author":"C Taylor","year":"2009","unstructured":"Taylor, C. & Hobbs, F. D. R. Type 2 diabetes, thiazolidinediones, and cardiovascular risk. Br. J. Gen. Pract. 59, 520. https:\/\/doi.org\/10.3399\/bjgp09X453440 (2009).","journal-title":"Br. J. Gen. Pract."},{"key":"27173_CR13","doi-asserted-by":"publisher","unstructured":"Dzobo, K. The role of natural products as sources of therapeutic agents for innovative drug discovery. Compr. Pharmacol. 408\u2013422. https:\/\/doi.org\/10.1016\/B978-0-12-820472-6.00041-4 (2022).","DOI":"10.1016\/B978-0-12-820472-6.00041-4"},{"key":"27173_CR14","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1038\/s41598-020-79472-y","volume":"11","author":"P Mosaddeghi","year":"2021","unstructured":"Mosaddeghi, P. et al. A systems Pharmacology approach to identify the autophagy-inducing effects of traditional Persian medicinal plants. Sci. Rep. 11, 336. https:\/\/doi.org\/10.1038\/s41598-020-79472-y (2021).","journal-title":"Sci. Rep."},{"key":"27173_CR15","doi-asserted-by":"publisher","first-page":"184","DOI":"10.3390\/ddc3010011","volume":"3","author":"N Chaachouay","year":"2024","unstructured":"Chaachouay, N. & Zidane, L. Plant-Derived natural products: A source for drug discovery and development. Drugs Drug Candidates. 3, 184\u2013207. https:\/\/doi.org\/10.3390\/ddc3010011 (2024).","journal-title":"Drugs Drug Candidates"},{"key":"27173_CR16","doi-asserted-by":"publisher","first-page":"13278","DOI":"10.1038\/s41598-023-39279-z","volume":"13","author":"C Li","year":"2023","unstructured":"Li, C. et al. The effect of resveratrol, Curcumin and Quercetin combination on immuno-suppression of tumor microenvironment for breast tumor-bearing mice. Sci. Rep. 13, 13278. https:\/\/doi.org\/10.1038\/s41598-023-39279-z (2023).","journal-title":"Sci. Rep."},{"key":"27173_CR17","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.jbior.2017.09.012","volume":"67","author":"JA McCubrey","year":"2018","unstructured":"McCubrey, J. A. et al. Effects of berberine, curcumin, Resveratrol alone and in combination with chemotherapeutic drugs and signal transduction inhibitors on cancer cells\u2014Power of nutraceuticals. Adv. Biol. Regul. 67, 190\u2013211. https:\/\/doi.org\/10.1016\/j.jbior.2017.09.012 (2018).","journal-title":"Adv. Biol. Regul."},{"key":"27173_CR18","doi-asserted-by":"publisher","unstructured":"Banaszak, M., G\u00f3rna, I., Wo\u017aniak, D., Przys\u0142awski, J. & Drzyma\u0142a-Czy\u017c, S. The impact of Curcumin, Resveratrol, and cinnamon on modulating oxidative stress and antioxidant activity in type 2 diabetes: moving beyond an Anti-Hyperglycaemic evaluation. Antioxid. (Basel). 13. https:\/\/doi.org\/10.3390\/antiox13050510 (2024).","DOI":"10.3390\/antiox13050510"},{"key":"27173_CR19","doi-asserted-by":"publisher","first-page":"554","DOI":"10.2337\/db09-0482","volume":"59","author":"J-H Um","year":"2010","unstructured":"Um, J-H. et al. AMP-activated protein kinase-deficient mice are resistant to the metabolic effects of Resveratrol. Diabetes 59, 554\u2013563. https:\/\/doi.org\/10.2337\/db09-0482 (2010).","journal-title":"Diabetes"},{"key":"27173_CR20","doi-asserted-by":"publisher","first-page":"551","DOI":"10.2337\/db09-1732","volume":"59","author":"MD Fullerton","year":"2010","unstructured":"Fullerton, M. D. & Steinberg, G. R. SIRT1 takes a backseat to AMPK in the regulation of insulin sensitivity by Resveratrol. Diabetes 59, 551\u2013553. https:\/\/doi.org\/10.2337\/db09-1732 (2010).","journal-title":"Diabetes"},{"key":"27173_CR21","doi-asserted-by":"publisher","unstructured":"Hussain, Y. et al. How Curcumin targets inflammatory mediators in diabetes: therapeutic insights and possible solutions. Molecules 27 https:\/\/doi.org\/10.3390\/molecules27134058 (2022).","DOI":"10.3390\/molecules27134058"},{"key":"27173_CR22","doi-asserted-by":"publisher","first-page":"e4030","DOI":"10.1002\/cbf.4030","volume":"42","author":"MY Zamanian","year":"2024","unstructured":"Zamanian, M. Y. et al. NF-\u03baB pathway as a molecular target for Curcumin in diabetes mellitus treatment: focusing on oxidative stress and inflammation. Cell. Biochem. Funct. 42, e4030. https:\/\/doi.org\/10.1002\/cbf.4030 (2024).","journal-title":"Cell. Biochem. Funct."},{"key":"27173_CR23","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s40203-020-00065-8","volume":"9","author":"MMV Rao","year":"2021","unstructured":"Rao, M. M. V. & Hariprasad, T. P. N. In Silico analysis of a potential antidiabetic phytochemical erythrin against therapeutic targets of diabetes. Silico Pharmacol. 9, 5. https:\/\/doi.org\/10.1007\/s40203-020-00065-8 (2021).","journal-title":"Silico Pharmacol."},{"key":"27173_CR24","doi-asserted-by":"publisher","first-page":"2602","DOI":"10.1039\/C4FO00420E","volume":"5","author":"S-H Lee","year":"2014","unstructured":"Lee, S-H. et al. Octaphlorethol A: a potent \u03b1-glucosidase inhibitor isolated from ishige foliacea shows an anti-hyperglycemic effect in mice with streptozotocin-induced diabetes. Food Funct. 5, 2602\u20132608. https:\/\/doi.org\/10.1039\/C4FO00420E (2014).","journal-title":"Food Funct."},{"key":"27173_CR25","doi-asserted-by":"publisher","first-page":"S455","DOI":"10.12980\/APJTB.4.2014C1049","volume":"4","author":"V Sivajothi","year":"2014","unstructured":"Sivajothi, V. & Dakappa, S. S. In vitro and in Silico antidiabetic activity of Pyran ester derivative isolated from tragia Cannabina. Asian Pac. J. Trop. Biomed. 4, S455\u2013S459. https:\/\/doi.org\/10.12980\/APJTB.4.2014C1049 (2014).","journal-title":"Asian Pac. J. Trop. Biomed."},{"key":"27173_CR26","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1016\/j.str.2011.03.019","volume":"19","author":"MV Shapovalov","year":"2011","unstructured":"Shapovalov, M. V. & Dunbrack, R. L. J. A smoothed backbone-dependent rotamer library for proteins derived from adaptive kernel density estimates and regressions. Structure 19, 844\u2013858. https:\/\/doi.org\/10.1016\/j.str.2011.03.019 (2011).","journal-title":"Structure"},{"key":"27173_CR27","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.jmgm.2005.12.005","volume":"25","author":"J Wang","year":"2006","unstructured":"Wang, J., Wang, W., Kollman, P. A. & Case, D. A. Automatic atom type and bond type perception in molecular mechanical calculations. J. Mol. Graph Model. 25, 247\u2013260. https:\/\/doi.org\/10.1016\/j.jmgm.2005.12.005 (2006).","journal-title":"J. Mol. Graph Model."},{"key":"27173_CR28","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1021\/ci3001277","volume":"52","author":"JJ Irwin","year":"2012","unstructured":"Irwin, J. J., Sterling, T., Mysinger, M. M., Bolstad, E. S. & Coleman, R. G. ZINC: A free tool to discover chemistry for biology. J. Chem. Inf. Model. 52, 1757\u20131768. https:\/\/doi.org\/10.1021\/ci3001277 (2012).","journal-title":"J. Chem. Inf. Model."},{"key":"27173_CR29","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1021\/ci049714+","volume":"45","author":"JJ Irwin","year":"2005","unstructured":"Irwin, J. J. & Shoichet, B. K. ZINC\u2013a free database of commercially available compounds for virtual screening. J. Chem. Inf. Model. 45, 177\u2013182. https:\/\/doi.org\/10.1021\/ci049714+ (2005).","journal-title":"J. Chem. Inf. Model."},{"key":"27173_CR30","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/1758-2946-3-33","volume":"3","author":"NM O\u2019Boyle","year":"2011","unstructured":"O\u2019Boyle, N. M. et al. Open babel: an open chemical toolbox. J. Cheminform. 3, 33. https:\/\/doi.org\/10.1186\/1758-2946-3-33 (2011).","journal-title":"J. Cheminform"},{"key":"27173_CR31","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1002\/jcc.21334","volume":"31","author":"O Trott","year":"2010","unstructured":"Trott, O. & Olson, A. J. AutoDock vina: improving the speed and accuracy of Docking with a new scoring function, efficient optimization, and multithreading. J. Comput. Chem. 31, 455\u2013461. https:\/\/doi.org\/10.1002\/jcc.21334 (2010).","journal-title":"J. Comput. Chem."},{"key":"27173_CR32","doi-asserted-by":"publisher","first-page":"W443","DOI":"10.1093\/nar\/gkv315","volume":"43","author":"S Salentin","year":"2015","unstructured":"Salentin, S., Schreiber, S., Haupt, V. J., Adasme, M. F. & Schroeder, M. PLIP: fully automated protein\u2013ligand interaction profiler. Nucleic Acids Res. 43, W443\u2013W447. https:\/\/doi.org\/10.1093\/nar\/gkv315 (2015).","journal-title":"Nucleic Acids Res."},{"key":"27173_CR33","doi-asserted-by":"publisher","first-page":"W530","DOI":"10.1093\/nar\/gkab294","volume":"49","author":"MF Adasme","year":"2021","unstructured":"Adasme, M. F. et al. PLIP 2021: expanding the scope of the protein\u2013ligand interaction profiler to DNA and RNA. Nucleic Acids Res. 49, W530\u2013W534. https:\/\/doi.org\/10.1093\/nar\/gkab294 (2021).","journal-title":"Nucleic Acids Res."},{"key":"27173_CR34","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1186\/1471-2105-14-128","volume":"14","author":"EY Chen","year":"2013","unstructured":"Chen, E. Y. et al. Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool. BMC Bioinform. 14, 128. https:\/\/doi.org\/10.1186\/1471-2105-14-128 (2013).","journal-title":"BMC Bioinform."},{"key":"27173_CR35","doi-asserted-by":"publisher","first-page":"e90","DOI":"10.1002\/cpz1.90","volume":"1","author":"Z Xie","year":"2021","unstructured":"Xie, Z. et al. Gene set knowledge discovery with enrichr. Curr. Protoc. 1, e90. https:\/\/doi.org\/10.1002\/cpz1.90 (2021).","journal-title":"Curr. Protoc."},{"key":"27173_CR36","doi-asserted-by":"publisher","first-page":"W90","DOI":"10.1093\/nar\/gkw377","volume":"44","author":"MV Kuleshov","year":"2016","unstructured":"Kuleshov, M. V. et al. Enrichr: a comprehensive gene set enrichment analysis web server 2016 update. Nucleic Acids Res. 44, W90\u2013W97. https:\/\/doi.org\/10.1093\/nar\/gkw377 (2016).","journal-title":"Nucleic Acids Res."},{"key":"27173_CR37","doi-asserted-by":"publisher","first-page":"D457","DOI":"10.1093\/nar\/gkv1070","volume":"44","author":"M Kanehisa","year":"2016","unstructured":"Kanehisa, M., Sato, Y., Kawashima, M., Furumichi, M. & Tanabe, M. KEGG as a reference resource for gene and protein annotation. Nucleic Acids Res. 44, D457\u2013D462. https:\/\/doi.org\/10.1093\/nar\/gkv1070 (2016).","journal-title":"Nucleic Acids Res."},{"key":"27173_CR38","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa, M. & Goto, S. KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 28, 27\u201330. https:\/\/doi.org\/10.1093\/nar\/28.1.27 (2000).","journal-title":"Nucleic Acids Res."},{"key":"27173_CR39","doi-asserted-by":"publisher","first-page":"D672","DOI":"10.1093\/nar\/gkae909","volume":"53","author":"M Kanehisa","year":"2025","unstructured":"Kanehisa, M., Furumichi, M., Sato, Y., Matsuura, Y. & Ishiguro-Watanabe, M. KEGG: biological systems database as a model of the real world. Nucleic Acids Res. 53, D672\u2013D677. https:\/\/doi.org\/10.1093\/nar\/gkae909 (2025).","journal-title":"Nucleic Acids Res."},{"key":"27173_CR40","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/75556","volume":"25","author":"M Ashburner","year":"2000","unstructured":"Ashburner, M. et al. Gene ontology: tool for the unification of biology. The gene ontology consortium. Nat. Genet. 25, 25\u201329. https:\/\/doi.org\/10.1038\/75556 (2000).","journal-title":"Nat. Genet."},{"key":"27173_CR41","doi-asserted-by":"publisher","first-page":"D331","DOI":"10.1093\/nar\/gkw1108","volume":"45","author":"The Gene Ontology Consortium","year":"2017","unstructured":"The Gene Ontology Consortium. Expansion of the gene ontology knowledgebase and resources. Nucleic Acids Res. 45, D331\u2013D338. https:\/\/doi.org\/10.1093\/nar\/gkw1108 (2017).","journal-title":"Nucleic Acids Res."},{"key":"27173_CR42","doi-asserted-by":"publisher","first-page":"108171","DOI":"10.1016\/j.cpc.2021.108171","volume":"271","author":"AP Thompson","year":"2022","unstructured":"Thompson, A. P. et al. LAMMPS - a flexible simulation tool for particle-based materials modeling at the atomic, meso, and continuum scales. Comput. Phys. Commun. 271, 108171. https:\/\/doi.org\/10.1016\/j.cpc.2021.108171 (2022).","journal-title":"Comput. Phys. Commun."},{"key":"27173_CR43","doi-asserted-by":"publisher","unstructured":"Ahmed, S. et al. Molecular Docking and dynamics simulation of natural compounds from betel leaves (Piper Betle L.) for investigating the potential Inhibition of Alpha-Amylase and Alpha-Glucosidase of type 2 diabetes. Molecules 2022;27. https:\/\/doi.org\/10.3390\/molecules27144526","DOI":"10.3390\/molecules27144526"},{"key":"27173_CR44","doi-asserted-by":"publisher","first-page":"101511","DOI":"10.1016\/j.imu.2024.101511","volume":"47","author":"BO Omiyale","year":"2024","unstructured":"Omiyale, B. O., Oyinloye, B. E., Ajiboye, B. O. & Ubah, C. S. Curated phytochemicals of Annona muricata modulate proteins linked to type II diabetes mellitus: molecular Docking studies, ADMET and DFT calculation. Inf. Med. Unlocked. 47, 101511. https:\/\/doi.org\/10.1016\/j.imu.2024.101511 (2024).","journal-title":"Inf. Med. Unlocked"},{"key":"27173_CR45","doi-asserted-by":"publisher","unstructured":"Macalalad, M. A. B. & Gonzales, A. A. In Silico screening and identification of antidiabetic inhibitors sourced from phytochemicals of Philippine plants against four protein targets of diabetes (PTP1B, DPP-4, SGLT-2, and FBPase). Molecules 28 https:\/\/doi.org\/10.3390\/molecules28145301 (2023).","DOI":"10.3390\/molecules28145301"},{"key":"27173_CR46","doi-asserted-by":"publisher","first-page":"4170703","DOI":"10.1155\/2023\/4170703","volume":"2023","author":"A Abdullah","year":"2023","unstructured":"Abdullah, A. et al. Molecular dynamics simulation and pharmacoinformatic integrated analysis of bioactive phytochemicals from Azadirachta indica (Neem) to treat diabetes mellitus. J. Chem. 2023, 4170703. https:\/\/doi.org\/10.1155\/2023\/4170703 (2023).","journal-title":"J. Chem."},{"key":"27173_CR47","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1007\/s40200-023-01249-7","volume":"22","author":"FO Balogun","year":"2023","unstructured":"Balogun, F. O. et al. Cheminformatics identification of modulators of key carbohydrate-metabolizing enzymes from C. cujete for type-2 diabetes mellitus intervention. J. Diabetes Metab. Disord. 22, 1299\u20131317. https:\/\/doi.org\/10.1007\/s40200-023-01249-7 (2023).","journal-title":"J. Diabetes Metab. Disord"},{"key":"27173_CR48","doi-asserted-by":"publisher","first-page":"100606","DOI":"10.1016\/j.phyplu.2024.100606","volume":"4","author":"MI Dar","year":"2024","unstructured":"Dar, M. I. et al. Exploring the anti-diabetic mechanism of selective phytochemicals identified from Gymnema sylvestre using TLC-UPLC-MS, complemented by in Silico studies. Phytomedicine Plus. 4, 100606. https:\/\/doi.org\/10.1016\/j.phyplu.2024.100606 (2024).","journal-title":"Phytomedicine Plus"},{"key":"27173_CR49","doi-asserted-by":"publisher","unstructured":"Choudhury, A. AA et al. Anti-diabetic drug discovery using the bioactive compounds of momordica Charantia by molecular Docking and molecular dynamics analysis. J. Biomol. Struct. Dyn. 1\u201315. https:\/\/doi.org\/10.1080\/07391102.2024.2313156 (n.d.).","DOI":"10.1080\/07391102.2024.2313156"},{"key":"27173_CR50","doi-asserted-by":"publisher","first-page":"11868","DOI":"10.3390\/cimb46110705","volume":"46","author":"R Singh","year":"2024","unstructured":"Singh, R. et al. Integrative network Pharmacology, molecular Docking, and dynamics simulations reveal the mechanisms of cinnamomum Tamala in diabetic nephropathy treatment: an in Silico study. Curr. Issues Mol. Biol. 46, 11868\u201311889. https:\/\/doi.org\/10.3390\/cimb46110705 (2024).","journal-title":"Curr. Issues Mol. Biol."},{"key":"27173_CR51","doi-asserted-by":"publisher","first-page":"102026","DOI":"10.1016\/j.jsps.2024.102026","volume":"32","author":"RY Halayal","year":"2024","unstructured":"Halayal, R. Y., Bagewadi, Z. K., Aldabaan, N. A., Shaikh, I. A. & Khan, A. A. Exploring the therapeutic mechanism of potential phytocompounds from Kalanchoe pinnata in the treatment of diabetes mellitus by integrating network pharmacology, molecular Docking and simulation approach. Saudi Pharm. J. 32, 102026. https:\/\/doi.org\/10.1016\/j.jsps.2024.102026 (2024).","journal-title":"Saudi Pharm. J."},{"key":"27173_CR52","doi-asserted-by":"publisher","first-page":"24936","DOI":"10.1038\/s41598-024-75570-3","volume":"14","author":"D Vijh","year":"2024","unstructured":"Vijh, D. & Gupta, P. GC\u2013MS analysis, molecular docking, and Pharmacokinetic studies on dalbergia Sissoo barks extracts for compounds with anti-diabetic potential. Sci. Rep. 14, 24936. https:\/\/doi.org\/10.1038\/s41598-024-75570-3 (2024).","journal-title":"Sci. Rep."},{"key":"27173_CR53","doi-asserted-by":"publisher","first-page":"1276444","DOI":"10.3389\/fphar.2023.1276444","volume":"14","author":"FI Sald\u00edvar-Gonz\u00e1lez","year":"2023","unstructured":"Sald\u00edvar-Gonz\u00e1lez, F. I., Navarrete-V\u00e1zquez, G. & Medina-Franco, J. L. Design of a multi-target focused library for antidiabetic targets using a comprehensive set of chemical transformation rules. Front. Pharmacol. 14, 1276444. https:\/\/doi.org\/10.3389\/fphar.2023.1276444 (2023).","journal-title":"Front. Pharmacol."},{"key":"27173_CR54","doi-asserted-by":"publisher","unstructured":"Yanni, S. & Translational ADMET for Drug Therapy: Principles, Methods and Pharmaceutical Applications (Wiley-Interscience, 2015). https:\/\/doi.org\/10.1002\/9781118838440","DOI":"10.1002\/9781118838440"},{"key":"27173_CR55","doi-asserted-by":"publisher","first-page":"109221","DOI":"10.1016\/j.foodhyd.2023.109221","volume":"146","author":"S Sahraeian","year":"2024","unstructured":"Sahraeian, S., Rashidinejad, A. & Golmakani, M-T. Recent advances in the conjugation approaches for enhancing the bioavailability of polyphenols. Food Hydrocoll. 146, 109221. https:\/\/doi.org\/10.1016\/j.foodhyd.2023.109221 (2024).","journal-title":"Food Hydrocoll."},{"key":"27173_CR56","doi-asserted-by":"publisher","unstructured":"Huang, X. et al. Combination of plant metabolites hinders starch digestion and glucose absorption while facilitating insulin sensitivity to diabetes. Front. Pharmacol. 15 https:\/\/doi.org\/10.3389\/fphar.2024.1362150 (2024).","DOI":"10.3389\/fphar.2024.1362150"},{"key":"27173_CR57","doi-asserted-by":"publisher","first-page":"10286","DOI":"10.1038\/s41598-024-61011-8","volume":"14","author":"H Gu","year":"2024","unstructured":"Gu, H. et al. Exploring the mechanism of Jinlida granules against type 2 diabetes mellitus by an integrative Pharmacology strategy. Sci. Rep. 14, 10286. https:\/\/doi.org\/10.1038\/s41598-024-61011-8 (2024).","journal-title":"Sci. Rep."},{"key":"27173_CR58","first-page":"220","volume":"48","author":"B Patwardhan","year":"2010","unstructured":"Patwardhan, B. & Vaidya, A. D. B. Natural products drug discovery: accelerating the clinical candidate development using reverse Pharmacology approaches. Indian J. Exp. Biol. 48, 220\u2013227 (2010).","journal-title":"Indian J. Exp. Biol."},{"key":"27173_CR59","doi-asserted-by":"publisher","first-page":"s21","DOI":"10.5530\/ijper.56.1s.39","volume":"56","author":"A Kausar","year":"2022","unstructured":"Kausar, A. et al. Identifying natural therapeutics against diabetes via Inhibition of dipeptidyl peptidase 4: molecular Docking and MD simulation study. Indian J. Pharm. Educ. Res. 56, s21\u201331. https:\/\/doi.org\/10.5530\/ijper.56.1s.39 (2022).","journal-title":"Indian J. Pharm. Educ. Res."},{"key":"27173_CR60","doi-asserted-by":"publisher","first-page":"16680","DOI":"10.1038\/s41598-024-66998-8","volume":"14","author":"J Yuan","year":"2024","unstructured":"Yuan, J. et al. Molecular dynamics-guided optimization of BGM0504 enhances dual-target agonism for combating diabetes and obesity. Sci. Rep. 14, 16680. https:\/\/doi.org\/10.1038\/s41598-024-66998-8 (2024).","journal-title":"Sci. Rep."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-27173-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-27173-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-27173-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T09:45:02Z","timestamp":1764927902000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-27173-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,5]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["27173"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-27173-9","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,5]]},"assertion":[{"value":"8 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study did not involve human participants or animals and solely utilized publicly available data; therefore, ethical approval and consent to participate are not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"43205"}}